drugset / Trial / NCT00292942
Study of the Safety of Intravenous Artesunate
Phase 1
Completed
26 enrolled
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to establish the safety, tolerability, and pharmacokinetics of a multiple dose of the antimalarial drug artesunate.
Timeline
- Start
- 2006-06-12
- Primary completion
- 2007-01-17
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artesunate | Small molecule | 2 mg/kg | Intravenous |
| Subject | Artesunate | Small molecule | 4 mg/kg | Intravenous |
| Subject | Artesunate | Small molecule | 8 mg/kg | Intravenous |